Standard BioTools Inc.

LAB | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.74

-$0.03 (-3.87%)

At close: Sep 21, 2026, 4:00 PM ET

$0.73

-$0.01 (-1.35%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.87%

(1D)

Rating

Updated: Sep 11, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $290.43M

1D Range

0.73 0.76

52W Range

0.63 1.72

Valuation (TTM)

PE -3.22

PB 0.54

EV/EBITDA 1.72

Valuation (NTM)

Forward PE N/A

Forward PEG -0.06

Price Target $3.25

Cash Flow

FCF Yield -44.7%

SBC Adj. FCF Yield -56.7%

SBC Impact -27.0%

Margins

Gross Margin 49.1%

Operating Margin -94.8%

FCF Margin -153.4%

Growth (CAGR)

Revenue 3Y | 5Y -7.1% | -10.6%

Dil EPS 3Y | 5Y 69.9% | 48.6%

FCF 3Y | 5Y 0.4% | -16.8%

Returns

ROA -13.9%

ROE -18.2%

ROIC -8.3%

Financial Health

Net Cash

$476.42M

Current Ratio 9.10

Interest Coverage -5,346.33

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop ther...

Sector Healthcare

Industry Medical - Specialties

Employees 387

IPO Date Feb 9, 2011

Website www.standardbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 3, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$3.25

Upside

+339.19%

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞